These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1546832)

  • 21. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
    Arens PJ
    Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
    Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxygen saturation during sleep in chronic obstructive lung diseases before and after bronchodilator therapy. A controlled, prospective study in 36 patients].
    Schmid T; Dreher D; Karrer W
    Schweiz Med Wochenschr; 1988 Nov; 118(45):1645-50. PubMed ID: 3187481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does aminophylline improve nocturnal hypoxia in patients with chronic airflow obstruction?
    Ebden P; Vathenen AS
    Eur J Respir Dis; 1987 Nov; 71(5):384-7. PubMed ID: 3443162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of doxofylline versus theophylline on sleep architecture in COPD patients.
    Sacco C; Braghiroli A; Grossi E; Donner CF
    Monaldi Arch Chest Dis; 1995 Apr; 50(2):98-103. PubMed ID: 7613555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease.
    Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep and respiratory function after withdrawal of noninvasive ventilation in patients with chronic respiratory failure.
    Petitjean T; Philit F; Germain-Pastenne M; Langevin B; Guérin C
    Respir Care; 2008 Oct; 53(10):1316-23. PubMed ID: 18811993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of protriptyline on day and night time oxygenation in patients with chronic obstructive pulmonary disease].
    Lin CC
    J Formos Med Assoc; 1993 Dec; 92 Suppl 4():S232-6. PubMed ID: 7910081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.
    Grassi V; Nicora M; Beretta A
    Int J Clin Pharmacol Res; 1987; 7(5):337-44. PubMed ID: 3667006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
    Kaik G
    Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interactions of theophylline and nifedipine].
    Luther R; Wichert H; Köhler E; Banditt P; Walther H
    Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sleep quality and nocturnal hypoxemia in patients with chronic obstructive pulmonary disease].
    Lin CC; Huang WC
    J Formos Med Assoc; 1992 Sep; 91 Suppl 3():S232-8. PubMed ID: 1362910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease.
    Bruguerolle B; Philip-Joet F; Parrel M; Arnaud A
    Chronobiol Int; 1987; 4(3):381-5. PubMed ID: 3315267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Euphylong in standard dosage: comparison with an international retard preparation for twice-daily administration in recommended dosage].
    Siemon G; Huber W; Maier-Stocker P
    Pneumologie; 1991 Nov; 45 Suppl 4():853-7. PubMed ID: 1812479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of nocturnal desaturation on pulmonary hemodynamics in patients with overlap syndrome (chronic obstructive pulmonary disease and obstructive sleep apnea)].
    Hawryłkiewicz I; Pałasiewicz G; Pływaczewski R; Sliwiński P; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(1-2):37-43. PubMed ID: 10967900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5-15 micrograms/ml.
    Self TH; Heilker GM; Alloway RR; Kelso TM; Abou-Shala N
    Pharmacotherapy; 1993; 13(6):590-4. PubMed ID: 8302682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variation in plasma theophylline concentrations during maintenance therapy with a sustained-release preparation in patients with obstructive airways disease.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1984 Jul; 18(1):27-30. PubMed ID: 6743488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.